Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Metastatic cancer with unknown primary.

B R Greenberg1, H J Lawrence

  • 1University of Connecticut Health Center, Farmington.

The Medical Clinics of North America
|September 1, 1988
PubMed
Summary

Diagnosing unknown primary cancer requires pathologist-oncologist collaboration and comprehensive pathology, including immunohistology for undifferentiated tumors. A selective search for treatable cancers is cost-effective, as the primary site is often not found.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A comparison of three methods for detecting KRAS mutations in formalin-fixed colorectal cancer specimens.

British journal of cancer·2012
Same author

Tamoxifen metabolite concentrations, CYP2D6 genotype, and breast cancer outcomes.

Clinical pharmacology and therapeutics·2011
Same author

Nucleophosmin mutations in acute myeloid leukemia in children.

Leukemia·2007
Same author

HOX genes: not just myeloid oncogenes any more.

Leukemia·2005
Same author

Abdominal presentation of Burkitt's lymphoma in an HIV-positive patient.

AIDS patient care and STDs·2004
Same author

Measuring stem cell frequency in epidermis: a quantitative in vivo functional assay for long-term repopulating cells.

Proceedings of the National Academy of Sciences of the United States of America·2003

Area of Science:

  • Oncology
  • Pathology
  • Cancer Diagnosis

Background:

  • Management of unknown primary carcinoma necessitates a multidisciplinary approach.
  • Accurate pathological diagnosis is critical, especially for undifferentiated tumors.

Purpose of the Study:

  • To outline essential diagnostic strategies for unknown primary carcinomas.
  • To emphasize cost-effective and targeted diagnostic approaches.

Main Methods:

  • Comprehensive pathological examination, including immunohistology and electron microscopy for undifferentiated tumors.
  • Selective diagnostic workup focusing on common and treatable primary sites.
  • Avoidance of extensive radiographic and imaging studies.

Main Results:

  • Primary tumor site remains unidentified in a majority of cases despite extensive evaluation.
  • Specific diagnostic pathways are recommended for adenocarcinomas (prostate, breast, ovary) and undifferentiated tumors (small cell lung cancer, lymphomas, germ cell tumors).
  • Axillary adenocarcinoma metastases in women suggest breast cancer; cervical squamous cell carcinoma metastases can be cured even without primary site detection.

Conclusions:

  • Close pathologist-oncologist cooperation is vital for effective patient management.
  • A selective, pathology-driven approach is more cost-effective than broad imaging.
  • Treatment should prioritize palliation or cure, considering specific tumor types and presentations.

Related Experiment Videos